Menu

A Nobel Pursuit

Watch as Nobel laureate Venki Ramakrishnan, who wrote the December Reading Frames essay, discusses Brexit and the importance of sharing scientific insights with the public.

Dec 10, 2018
The Scientist Staff

Read the full story.

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

StemExpress Announces New Distribution Partnerships&nbsp
StemExpress Announces New Distribution Partnerships&nbsp
To continue meeting the needs of clients around the world, StemExpress announces the expansion of its global distribution network to include the Asia Pacific and Australia, adding to their existing networks in North America, Europe, and North Africa.  
Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing
Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing
Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can now rely on this compact, portable and easy-to-use instrument to run Lonza’s MycoAlert™ Mycoplasma Detection Assays and obtain highly reliable results within just 20 minutes.
FUJIFILM Irvine Scientific Introduces Low Hydrolysate Medium For Insect Cell Expression Systems
FUJIFILM Irvine Scientific Introduces Low Hydrolysate Medium For Insect Cell Expression Systems
FUJIFILM Irvine Scientific, Inc., a world leader in the optimization and manufacture of cell culture media, today announced the introduction of IS Sf Insect medium. The serum-free, animal component-free, low hydrolysate medium is formulated for scalability for the consistent growth and yields of proteins, viral vectors and viral-like particles using baculovirus expression systems (BEVS), in Sf9 and Sf21 cells.
Improving Preclinical Discovery of CRISPR Engineered Immune Cell Therapies
Improving Preclinical Discovery of CRISPR Engineered Immune Cell Therapies
There is an urgent need to characterize the potency and efficacy of CRISPR-Cas9-modified inducible pluripotent stem cell-derived natural killer cells for preclinical cancer immunotherapy research. IsoPlexis' single-cell proteomics system addresses this challenge by connecting each immune cell to cytokine secretion and thereby correlating them to in vivo outcome across a range of disease areas.